Carter's, Inc. (CRI) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$35.75
Price Target
$37.00
Target Range
$33.00 — $40.00
Analyst Rating
Buy
Forward P/E10.8x
Trailing P/E13.8x
Forward PEG15.21
Implied Growth—
Median Target$38.00
Analyst Spread18.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$33
-7.7%
Consensus
$37
+3.5%
Bull Case
$40
+11.9%
Valuation Model TargetsConfidence: 58/100
Bear$27
Base$44
Bull$116
CRI Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Carter's, Inc. (CRI) has a Wall Street consensus price target of $37.00, based on estimates from 24 covering analysts. With the stock currently trading at $35.75, this represents a potential upside of +3.5%. The company has a market capitalization of $1.32B.
Analyst price targets range from a low of $33.00 to a high of $40.00, representing a 19% spread in expectations. The median target of $38.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 12 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 4 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CRI trades at a trailing P/E of 13.8x and forward P/E of 10.8x. The forward PEG ratio of 15.21 reflects a premium valuation.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $43.74, with bear and bull scenarios of $27.25 and $115.78 respectively. Model confidence stands at 58/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Consumer Cyclical stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+11.6%
Avg Forward P/E15.3x
Peers with Coverage8 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 GESGuess', Inc. | $877M | $16.81 | $26.19 | +55.8% | Hold | 10.4x | 32 |
 PVHPVH Corp. | $4.1B | $88.62 | $100.00 | +12.8% | Buy | 8.1x | 38 |
 HBIHanesbrands Inc. | $2.3B | $6.47 | $7.25 | +12.1% | Buy | 9.8x | 34 |
 RLRalph Lauren Corporation | $47.9B | $353.55 | $428.75 | +21.3% | Buy | 21.7x | 48 |
 VFCV.F. Corporation | $7.5B | $19.06 | $20.27 | +6.3% | Hold | 23.1x | 58 |
 COLMColumbia Sportswear Company | $3.3B | $63.32 | $63.33 | +0.0% | Hold | 18.3x | 28 |
 PLCEThe Children's Place, Inc. | $74M | $3.36 | — | — | — | — | — |
 DXLGDestination XL Group, Inc. | $35M | $0.64 | — | — | — | — | — |
 GIIIG-III Apparel Group, Ltd. | $1.3B | $31.30 | $33.75 | +7.8% | Buy | 10.8x | 29 |
 OXMOxford Industries, Inc. | $675M | $45.37 | $34.67 | -23.6% | Buy | 20.3x | 21 |
Upside Potential Comparison
GESRLPVHHBIGIIIVFCCOLMOXMSee CRI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRI vs AMZN
Side-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonCRI — Frequently Asked Questions
Quick answers to the most common questions about buying CRI stock.
What is the CRI stock price target for 2026?
The consensus price target for CRI is $37, close to the current price of $35.75 (3.5% implied move). Based on 24 analyst estimates, the stock appears fairly valued near current levels.
Is CRI a buy, sell, or hold?
CRI has a consensus rating of "Buy" based on 24 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $37 implies 3.5% upside from current levels.
Is CRI stock overvalued or undervalued?
With a forward P/E of 10.7977x, CRI trades at a relatively low valuation. The consensus target of $37 implies 3.5% appreciation, suggesting the market may be pricing in risks.
How high can CRI stock go?
The most bullish Wall Street analyst has a price target of $40 for CRI, while the most conservative target is $33. The consensus of $37 represents the median expectation. Our quantitative valuation model projects a bull case target of $116 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CRI stock?
CRI is well covered by analysts, with 24 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 12 have Buy ratings, 8 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CRI stock forecast?
The 12-month CRI stock forecast based on 24 Wall Street analysts shows a consensus price target of $37, with estimates ranging from $33 (bear case) to $40 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $44, with bear/bull scenarios of $27/$116.
What is CRI's fair value based on fundamentals?
Our quantitative valuation model calculates CRI's fair value at $44 (base case), with a bear case of $27 and bull case of $116. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 58/100.
What is CRI's forward P/E ratio?
CRI trades at a forward P/E ratio of 10.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CRI stock?
CRI appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $37 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CRI price targets vary so much?
CRI analyst price targets range from $33 to $40, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $37 consensus represents the middle ground. Our model's $27-$116 range provides an independent fundamental perspective.